Halozyme Therapeutics Inc (HALO)

38.69 -0.14  -0.36% NASDAQ Oct 22, 13:09 USD
View Full Chart
Price Chart
View All HALO News


View All Events


Date Type Description
11/02/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
11/02/2021 Earnings Results Q3 2021 Earnings Results
08/09/2021 Earnings Results Q2 2021 Earnings Results
08/09/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
05/05/2021 11:00 EST AGM 2020 Annual General Meeting
02/23/2021 Earnings Results Q4 2020 Earnings Results
02/23/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/02/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
  • URL: https://www.halozyme.com
  • Investor Relations URL: https://ir.halozyme.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 02, 2021
  • Last Earnings Release: Aug. 09, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
ARTSX Artisan Small Cap Investor 5.36%
JSJFX JHancock Small Cap Growth R6 2.68%
PBE Invesco Dynamic Biotech & Genome ETF 2.64%
IBBJ Defiance Nasdaq Junior Biotechnology ETF 1.76%
BIGZ BlackRock Innovation and Growth Trust 1.67%
BUISX Buffalo Small Cap Institutional 1.66%
JGLYX JPMorgan Small Cap Growth R4 1.35%
FVUSA04AWV JNL/Invesco Small Cap Growth I 1.16%
DCCRX Delaware Small Cap Core R 0.94%
VTWG Vanguard Russell 2000 Growth ETF 0.39%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.